Quantcast



Shareholder uprising against PPD merger quelled by settlement (access required)

But not all investors are happy with agreement which allows $3.9 billion deal to proceed

Despite objections from one institutional shareholder, the North Carolina Business Court has approved the settlement of a class action against Wilmington-based clinical research company Pharmaceutical Product Development Inc. and two private equity firms.
By Phillip Bantz
Published: June 15, 2012
Time posted: 4:47 pm


POST A COMMENT

Comments are closed.


The Dolan Company